North America Psychedelic Drugs Market is expected to grow with the healthy CAGR of 16.3% in the forecast period 2020 to 2027. The years considered for study are as mentioned below.
Access Full Report at https://www.databridgemarketresearch.com/reports/north-america-psychedelic-drugs-market
Psychedelic drugs market is a highly consolidated market, which includes specific number of key players as well as local players. The market has witnessed increased various strategic developments owing to favourable market scenario.
The major players dealing in psychedelic drugs market are introducing strong range of product portfolio. This has also helped the company to maximize the sales with enhanced product portfolio.
Jazz Pharmaceuticals, Inc. is the dominating player in psychedelic drugs market and the other players in the market includes Johnson & Johnson Services, Inc., Celon Pharma SA, COMPASS, usonainstitute.org, Develco pharma schweiz ag , Doughlas pharmaceuticals limited ,NeuroRX, Inc, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals, LLC., AVADEL PHARMACEUTICALS, PLC among others.
Jazz Pharmaceuticals, Inc.:
Jazz Pharmaceuticals, Inc. headquartered in Dublin, Ireland was incorporated in 2013. The company is engaged in turning biopharmaceutical discoveries into novel changing drugs to treat rare or complex diseases. The company is providing products under the categories Medicine (our medicines, drug safety, and medical information), research (pipeline, clinical trials, extended access, and independent scientific research). The company is constantly engaged in the manufacture and development of psychedelic drugs.
It also has direct sales representatives and distributors in North America, Europe through its subsidiaries Jazz Pharmaceuticals Ireland Limited (Ireland), Jazz Financing Eye Designed Activity Company (Ireland), Jazz Capital Limited (Ireland), Jazz Pharmaceuticals, Inc. (US), Celator Pharmaceuticals, Inc. (US) among others
Johnson & Johnson Services, Inc.:
Johnson & Johnson Services, Inc. headquartered in New Jersey, U.S. was founded in 1886. The company is engaged in research and development, manufacturing and sales of a wide range of products in the health care sector. The company is providing products under the categories of consumer health products, medical devices and pharmaceutical products. The company operates in the pharmaceutical, medical device and consumer segments. Market focus is under the products pharmaceutical segment. The company is constantly engaged in the manufacture and development of psychedelic drugs.
The company has widespread presence across the globe such as Europe, Middle East & Africa, Asia-Pacific, and Americas through its subsidiaries Johnson & Johnson Vision Care, Inc. (U.S.), Neutrogena (U.S.), DePuy Synthes (U.S.), Ethicon USA, LLC. (U.S.), Janssen Global Services, LLC (Belgium) among others.
Global Psychedelic Drugs Market - Industry Trends and Forecast to 2026
U.S. Psychedelic Drugs Market – Industry Trends and Forecast to 2027
Europe Psychedelic Drugs Market – Industry Trends and Forecast to 2027
North America Psychedelic Drugs Market – Industry Trends and Forecast to 2027